Ballerup, Denmark

Louis B Hansen

This inventor holds 1 USPTO granted patent. Top assignee: Novo Industri A/s. Active years: 1988.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Louis B Hansen. Retrieved from https://idiyas.com/inventor/louis-b-hansen-bk1fe0nc

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 1988

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Louis B Hansen

Introduction

Louis B Hansen is a notable inventor based in Ballerup, Denmark. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that affect the central nervous system. His work has implications for various therapeutic applications.

Latest Patents

Hansen holds a patent for a novel class of compounds known as 2,3,4,5-tetrahydro-1H-3-benzazepines. This patent describes the unique properties of these compounds, which feature substituents such as furyl, thienyl, and pyridyl. The compounds exhibit interesting central nervous system and cardiovascular effects, making them valuable in medical research and potential treatments.

Career Highlights

Throughout his career, Hansen has been associated with Novo Industri A/S, a leading company in the pharmaceutical industry. His work has focused on innovative drug development, contributing to advancements in therapeutic options for patients.

Collaborations

Hansen has collaborated with esteemed colleagues, including Claus Braestrup and Peter H Andersen. These partnerships have fostered a collaborative environment that enhances research and development efforts.

Conclusion

Louis B Hansen's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his importance as an inventor. His work continues to influence the development of new therapeutic agents.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…